1380 related articles for article (PubMed ID: 15800375)
1. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
6. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of VIP-stimulated cyclic AMP formation in chick brain.
Nowak JZ; Sedkowska P; Zawilska JB; Gozes I; Brenneman DE
J Mol Neurosci; 2003 Apr; 20(2):163-72. PubMed ID: 12794310
[TBL] [Abstract][Full Text] [Related]
8. PAC1 receptors in chick cerebral cortex: characterization by binding of pituitary adenylate cyclase-activating polypeptide, [125I]-PACAP27.
Zawilska JB; Niewiadomski P; Nowak JZ
Neurosci Lett; 2003 Feb; 338(2):155-8. PubMed ID: 12566176
[TBL] [Abstract][Full Text] [Related]
9. Effect of different forms of vasoactive intestinal peptide on cAMP formation in the mammalian cerebral cortex.
Dejda A; Gendek-Kubiak H; Nowak JZ
Pol J Pharmacol; 2004; 56(4):421-5. PubMed ID: 15520496
[TBL] [Abstract][Full Text] [Related]
10. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
[TBL] [Abstract][Full Text] [Related]
12. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
Nowak JZ; Kuba K
J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
Nowak JZ; Kuba K; Zawilska JB
Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
D'Agata V; Cavallaro S; Stivala F; Canonico PL
Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Margiotta JF; Pardi D
Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
[TBL] [Abstract][Full Text] [Related]
19. Identification of a VIP-specific receptor in guinea pig tenia coli.
Teng BQ; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
[TBL] [Abstract][Full Text] [Related]
20. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
